Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Devices In The Home: FDA Panel Explores New Ways To Provide Instructions

This article was originally published in The Gray Sheet

Executive Summary

As medical devices move out of the hands of trained health professionals and into the home, FDA and manufacturers need to find new ways to teach people how to use them safely, according to agency advisors.

You may also be interested in...



Regulatory News In Brief

News from FDA, the Government Accountability Office and the Federal Trade Commission.

Risk Communication Plan On Track, FDA Staffer Reports

About a year into the implementation of FDA's risk communication plan, the agency has met most of its 2010 goals, such as publishing a risk communication research agenda, designing surveys about public understanding and improving procedures to test communications more quickly.

Risk Communication Plan On Track, FDA Staffer Reports

About a year into the implementation of FDA's risk communication plan, the agency has met most of its 2010 goals, such as publishing a risk communication research agenda, designing surveys about public understanding and improving procedures to test communications more quickly.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029584

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel